IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of lost share certificates27-10-2021
27-10-2021
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Shareholding for the Period Ended September 30, 2021
IOL Chemicals & Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here18-10-2021
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Abhay Raj SinghDesignation :- Company Secretary and Compliance Officer16-10-2021
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September 202116-10-2021
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Approval Of Korean Ministry Of Food And Drug Safety (Korean FDA) For Company'S API Products 'Ibuprofen' & 'Fenofibrate'
Pursuant to Regulation 30 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform that the Company has received approval of Korean Ministry of Food and Drug Safety (Korean FDA) for Company's Pharmaceuticals API products 'IBUPROFEN and 'FENOFIBRATE'. The approval of Korean FDA re-establishes the Company's efforts to keep the highest quality standards and to increase presence in the regulated markets. This will strengthen Company's presence in South Korean market.14-10-2021
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Dear Sir, Pursuant to Regulation 47 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith copy of notice regarding loss of Share Certificates published in 'Economic Times' and 'Punjabi Jagran' on 13th October 2021. This is for your information and record.13-10-2021
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of lost share certificates12-10-2021
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Closure of Trading Window
Pursuant to the requirements of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's 'Code of Conduct to Regulate, Monitor and Reporting of Trading by Designated Persons' the Trading Window for dealing in the securities of the Company, shall remain closed for all the designated persons and their immediate relatives from 01st October 2021 till the expiry of 48 hours after the declaration of financial results for quarter and half year ended 30th September 2021 are made public. During the closure of Trading Window, Insiders are also advised not to deal in the shares of the Company.30-09-2021
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of duplicate share certificates27-09-2021
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Resurgent India virtual conference' organised by PhillipCapital20-09-2021